Clinical trials recruiting in Sigulda, Latvia
4
Recruiting trials
8
Conditions
Phase breakdown
Phase 3 4
Conditions recruiting in Sigulda, Latvia
| Condition | Trials |
|---|---|
| Depression | 2 |
| Major Depressive Disorder | 2 |
| Atrial Fibrillation (AF) | 1 |
| Atrial fibrillation | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Hypertension | 1 |
| Type 2 diabetes | 1 |
Recruiting trials in Sigulda, Latvia
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Common questions
How many clinical trials are recruiting in Sigulda, Latvia?
4 recruiting trials have at least one study site in Sigulda, Latvia.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.